PROCEPT BioRobotics Corporation
PRCT
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Společnost PROCEPT BioRobotics Corporation vyvíjí transformativní řešení v oblasti urologie. Vyvíjí, vyrábí a prodává AquaBeam Robotický systém, obrazově řízený, chirurgický robotický systém pro použití v minimálně invazivní urologické operaci se zaměřením na léčbu benigní hyperplazie prostaty (BPH). Společnost také navrhuje Aquablační terapii pro muže trpící příznaky nižšího močového ústrojí v důsledku BPH. K 31. prosinci 2021 měla instalační základnu 130 Robotických systémů AquaBeam po celém světě, zahrnující 78 v USA. Společnost PROCEPT BioRobotics Corporation byla založena v roce 2007 a sídlí v Redwood City v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
756
Založení
2021-09-15
Podobné společnosti
$ 31.28
+ $ 1.01
$ 15.11
+ $ 0.50
$ 20.96
+ $ 0.61
$ 2.62
- $ 0.05
$ 45.40
+ $ 0.53
$ 83.71
+ $ 1.92
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 308.1 | 308.1 | 224.5 | 136.2 | 75.0 | 34.5 | 7.7 | 6.2 | |
| Cost of Revenues | 111.8 | 111.8 | 87.4 | 65.1 | 37.9 | 18.6 | 9.0 | 8.1 | |
| Gross Profit | 196.2 | 196.2 | 137.1 | 71.0 | 37.1 | 15.9 | -1.3 | -1.9 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 76.4 | 83.3 | 79.2 | 69.2 | 68.2 | 58.4 | 53.4 | 44.5 | 43.6 | 35.1 | |
| Cost of Revenues | 30.1 | 29.3 | 27.4 | 25.0 | 24.6 | 21.5 | 21.9 | 19.5 | 23.6 | 16.2 | |
| Gross Profit | 46.3 | 54.0 | 51.7 | 44.2 | 43.7 | 36.9 | 31.5 | 25.0 | 19.9 | 18.9 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 48.4 | 29.0 | 19.0 | 16.3 | 13.1 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 131.8 | 88.8 | 51.0 | 30.3 | 28.5 | |
| Depreciation & Amortization | 6.4 | 6.4 | 5.2 | 3.8 | 2.0 | 0.1 | 3.0 | 2.6 | |
| Total Operating Expenses | 300.1 | 300.1 | 233.7 | 180.2 | 117.8 | 70.0 | 46.5 | 41.7 | |
| Operating Income | -103.9 | -103.9 | -96.6 | -109.2 | -80.7 | -54.2 | -47.8 | -43.6 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.2 | 11.6 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 36.3 | 32.9 | ||
| Depreciation & Amortization | 1.7 | 1.6 | 1.6 | 1.5 | 1.5 | 1.3 | 1.3 | 1.2 | 1.3 | 1.1 | ||
| Total Operating Expenses | 77.4 | 77.2 | 73.9 | 71.6 | 63.4 | 59.3 | 58.3 | 52.7 | 49.5 | 44.5 | ||
| Operating Income | -31.0 | -23.2 | -22.2 | -27.4 | -19.7 | -22.4 | -26.8 | -27.6 | -29.6 | -25.6 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 10.7 | 10.7 | 10.9 | 7.6 | 2.0 | 0.1 | 0.2 | 1.1 | |
| Interest Expense | 8.9 | 8.9 | 4.2 | 4.0 | 5.2 | 5.8 | 5.3 | 0.7 | |
| Other Expense | 8.5 | 8.5 | 5.2 | 3.3 | -6.4 | -5.7 | -5.2 | 1.6 | |
| IBT | -95.4 | -95.4 | -91.4 | -105.9 | -87.2 | -59.9 | -53.0 | -42.0 | |
| Income Tax Expense | 0.2 | 0.2 | 0.0 | 0.0 | 6.4 | 2.5 | 5.2 | 0.7 | |
| Net Income | -95.6 | -95.6 | -91.4 | -105.9 | -93.6 | -62.4 | -58.3 | -42.7 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.9 | 2.7 | 3.5 | 3.6 | 3.3 | 2.6 | 2.2 | 2.7 | 3.5 | 2.0 | ||
| Interest Expense | 6.2 | 0.9 | 0.9 | 0.9 | 1.0 | 1.1 | 1.0 | 1.0 | 1.1 | 1.0 | ||
| Other Expense | 1.4 | 1.8 | 2.6 | 2.7 | 0.9 | 1.5 | 1.2 | 1.7 | 2.1 | 1.0 | ||
| IBT | -29.7 | -21.4 | -19.6 | -24.7 | -18.9 | -21.0 | -25.6 | -26.0 | -27.5 | -24.6 | ||
| Income Tax Expense | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.8 | -1.1 | ||
| Net Income | -29.8 | -21.4 | -19.6 | -24.7 | -18.9 | -21.0 | -25.6 | -26.0 | -27.5 | -24.6 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.24 | $-2.11 | $-3.79 | $-1.66 | $-1.27 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.24 | $-2.11 | $-3.79 | $-1.66 | $-1.27 | |
| Shares Outstanding | 55.7 | 55.7 | 52.1 | 47.3 | 44.4 | 16.5 | 35.1 | 33.6 | |
| Diluted Shares Outstanding | 55.7 | 55.7 | 52.1 | 47.3 | 44.4 | 16.5 | 35.1 | 33.6 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.54 | $-0.51 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.54 | $-0.51 | ||
| Shares Outstanding | 55.7 | 55.7 | 55.4 | 54.9 | 53.8 | 52.0 | 51.6 | 51.0 | 50.6 | 48.3 | ||
| Diluted Shares Outstanding | 55.7 | 55.7 | 55.4 | 54.9 | 53.8 | 52.0 | 51.6 | 51.0 | 50.6 | 48.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 214.1 | 333.7 | 257.2 | 221.9 | 304.3 | 100.1 | 42.0 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 214.1 | 333.7 | 257.2 | 221.9 | 304.3 | 100.1 | 42.0 | |
| Accounts Receivable | 58.9 | 83.5 | 48.4 | 15.3 | 4.5 | 1.5 | 1.1 | |
| Inventory | 43.9 | 56.2 | 39.8 | 28.5 | 13.1 | 7.5 | 6.7 | |
| Other Current Assets | 5.0 | 8.5 | 5.2 | 6.2 | 4.2 | 0.7 | 0.6 | |
| Total Current Assets | 321.9 | 481.8 | 350.6 | 272.6 | 326.2 | 110.3 | 50.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 294.3 | 302.7 | 316.2 | 333.7 | 196.8 | 214.1 | 225.6 | 257.2 | 287.1 | 149.7 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 294.3 | 302.7 | 316.2 | 333.7 | 196.8 | 214.1 | 225.6 | 257.2 | 287.1 | 149.7 | |
| Accounts Receivable | 84.5 | 80.8 | 79.3 | 83.5 | 69.0 | 58.9 | 56.1 | 48.4 | 34.6 | 33.2 | |
| Inventory | 66.7 | 67.0 | 62.3 | 56.2 | 50.9 | 43.9 | 41.6 | 39.8 | 42.2 | 42.6 | |
| Other Current Assets | 8.7 | 7.1 | 7.6 | 8.5 | 6.3 | 5.0 | 5.9 | 5.2 | 4.8 | 4.5 | |
| Total Current Assets | 454.2 | 457.7 | 465.4 | 481.8 | 323.0 | 321.9 | 329.2 | 350.6 | 368.7 | 230.0 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 47.3 | 45.7 | 49.0 | 32.1 | 8.3 | 12.9 | 8.3 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 1.1 | 0.9 | 1.2 | 1.5 | 1.8 | 0.0 | 0.0 | |
| Long-Term Investments | 3.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 1.1 | 2.6 | 4.0 | 3.1 | 0.8 | 0.8 | 0.7 | |
| Total Long-Term Assets | 52.5 | 52.2 | 54.2 | 36.7 | 10.9 | 15.7 | 11.3 | |
| Total Assets | 374.4 | 534.0 | 404.7 | 309.3 | 337.0 | 126.0 | 62.0 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 47.9 | 46.9 | 46.7 | 45.7 | 45.9 | 47.3 | 48.4 | 49.0 | 47.7 | 37.9 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.7 | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 | 1.3 | |
| Long-Term Investments | 6.3 | 5.8 | 5.1 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | 3.0 | |
| Other Long-Term Assets | 2.4 | 1.9 | 1.4 | 2.6 | 1.3 | 1.1 | 1.2 | 0.9 | 3.5 | 3.2 | |
| Total Long-Term Assets | 57.3 | 55.4 | 54.0 | 52.2 | 51.2 | 52.5 | 53.7 | 54.1 | 52.5 | 42.4 | |
| Total Assets | 511.5 | 513.1 | 519.4 | 534.0 | 374.1 | 374.4 | 382.9 | 404.7 | 421.1 | 272.4 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 10.0 | 10.0 | 13.5 | 9.4 | 2.0 | 1.2 | 1.4 | |
| Short-Term Debt | 1.8 | 1.9 | 1.7 | 2.1 | 2.1 | 6.3 | 3.1 | |
| Other Current Liabilities | 24.6 | 29.6 | 23.4 | 20.9 | 11.1 | 6.8 | 2.2 | |
| Current Liabilities | 42.8 | 53.1 | 45.9 | 35.3 | 16.2 | 14.5 | 6.8 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 11.1 | 11.8 | 14.8 | 10.0 | 15.1 | 10.0 | 10.1 | 13.5 | 13.6 | 10.0 | |
| Short-Term Debt | 2.1 | 2.1 | 2.0 | 1.9 | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 | 2.4 | |
| Other Current Liabilities | 30.0 | 26.0 | 25.5 | 29.6 | 28.7 | 24.6 | 21.0 | 23.4 | 21.1 | 18.8 | |
| Current Liabilities | 53.9 | 49.7 | 52.1 | 53.1 | 53.6 | 42.8 | 38.7 | 45.9 | 41.4 | 35.9 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 51.4 | 78.3 | 77.5 | 75.2 | 52.0 | 48.5 | 23.2 | |
| Capital Leases | 27.8 | 28.8 | 26.2 | 26.1 | 4.1 | 5.8 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 122.6 | 131.8 | 124.0 | 112.3 | 69.9 | 308.9 | 205.8 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 76.8 | 77.3 | 77.8 | 78.3 | 78.8 | 79.2 | 79.7 | 77.5 | 78.0 | 78.4 | |
| Capital Leases | 27.4 | 27.8 | 28.3 | 28.8 | 29.2 | 27.8 | 30.0 | 26.2 | 28.4 | 29.5 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 131.3 | 127.3 | 130.2 | 131.8 | 132.9 | 122.6 | 118.9 | 124.0 | 121.8 | 116.5 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -506.2 | -546.0 | -454.6 | -348.7 | -261.5 | -201.7 | -148.6 | |
| Comprehensive Income | 0.0 | 0.1 | 0.1 | 0.0 | -0.1 | 0.0 | 0.0 | |
| Total Common Equity | 251.8 | 402.2 | 280.8 | 197.1 | 267.1 | -182.9 | -143.8 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -611.7 | -590.3 | -570.7 | -546.0 | -527.1 | -506.2 | -480.5 | -454.6 | -427.1 | -402.4 | |
| Comprehensive Income | 0.0 | -0.1 | 0.2 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Total Common Equity | 380.3 | 385.8 | 389.2 | 402.2 | 241.2 | 251.8 | 264.0 | 280.8 | 299.4 | 155.9 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
| Total Debt | 81.0 | 80.3 | 79.2 | 77.3 | 54.1 | 54.8 | 23.2 | |
| Book Value | 251.8 | 402.2 | 280.8 | 197.1 | 267.1 | -182.9 | -143.8 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 380.3 | 385.8 | 389.2 | 402.2 | 241.2 | 251.8 | 264.0 | 280.8 | 299.4 | 155.9 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -103.7 | -95.6 | -91.4 | -105.9 | -87.2 | -59.9 | -53.0 | -42.0 | |
| Depreciation & Amortization | 4.8 | 6.4 | 5.2 | 3.8 | 2.8 | 3.3 | 2.9 | 1.5 | |
| Stock-Based Compensation | 24.5 | 47.6 | 31.8 | 19.1 | 10.3 | 3.8 | 2.2 | 2.0 | |
| Change Working Capital | -18.5 | -7.8 | -47.3 | -26.2 | -11.5 | -4.7 | -0.5 | -3.5 | |
| Change In Accounts Receivable | -25.7 | -0.9 | -36.0 | -33.1 | -10.8 | -2.9 | -0.5 | 0.5 | |
| Change In Accounts Payable | 1.6 | 6.6 | -2.2 | 5.8 | 4.0 | 0.8 | -0.2 | -0.3 | |
| Change In Inventories | -0.6 | -14.5 | -17.2 | -9.8 | -15.3 | -6.1 | -3.1 | -5.1 | |
| Other Non-cash Items | 33.6 | 0.4 | 2.5 | 1.1 | 5.1 | -0.3 | -0.1 | -1.8 | |
| Cash from Operations | -91.8 | 0.0 | 0.0 | -108.0 | -80.4 | -57.3 | -48.3 | -43.8 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -29.8 | -21.4 | -19.6 | -24.7 | -18.9 | -21.0 | -25.6 | -26.0 | -27.5 | -24.6 | |
| Depreciation & Amortization | 1.7 | 1.6 | 1.6 | 1.5 | 1.5 | 1.3 | 1.3 | 1.2 | 1.3 | 1.1 | |
| Stock-Based Compensation | 10.8 | 14.5 | 12.2 | 10.1 | 9.1 | 8.5 | 8.0 | 6.3 | 5.0 | 5.3 | |
| Change Working Capital | 8.0 | -2.4 | -9.5 | -4.3 | -25.0 | -8.5 | -0.2 | -13.7 | -3.5 | -1.1 | |
| Change In Accounts Receivable | 2.2 | -4.4 | -2.7 | 3.9 | -14.8 | -10.6 | -2.8 | -7.7 | -13.8 | -1.4 | |
| Change In Accounts Payable | 5.9 | 0.0 | -2.3 | 3.8 | -5.4 | 5.2 | 0.3 | -2.3 | 5.9 | -2.3 | |
| Change In Inventories | -4.0 | 0.6 | -4.8 | -6.3 | -5.8 | -7.2 | -2.8 | -1.5 | 3.2 | 0.5 | |
| Other Non-cash Items | -1.1 | 1.0 | 0.3 | 0.5 | 0.9 | 0.8 | 0.8 | -0.1 | 12.2 | 4.8 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -24.8 | -18.9 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -17.5 | -9.4 | -4.4 | -25.2 | -2.7 | -0.6 | -0.2 | -7.6 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 50.8 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -17.5 | 0.0 | 0.0 | -25.2 | -2.7 | -0.6 | -0.2 | 43.2 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.9 | -2.9 | -2.8 | -1.8 | -1.2 | -0.2 | -1.0 | -1.9 | -8.7 | -5.8 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.7 | -5.8 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | -53.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 0.3 | 80.3 | 1.0 | 1.9 | 76.2 | -0.7 | 31.5 | 23.2 | |
| Issuance of Common Stock | 172.9 | 0.0 | 0.0 | 161.7 | 4.0 | 172.4 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 3.6 | 0.0 | 0.0 | 0.0 | 2.4 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 172.9 | 0.0 | 0.0 | 6.1 | 50.2 | 89.8 | 0.0 | 0.0 | |
| Cash from Financing | 172.9 | 0.0 | 0.0 | 167.8 | 3.6 | 262.1 | 106.8 | 26.5 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 78.9 | -0.4 | -0.4 | -0.4 | -0.4 | -0.4 | -0.4 | 2.2 | -0.5 | -1.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.9 | 162.1 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.6 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.9 | 162.1 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.9 | 162.1 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 63.6 | -47.2 | 76.5 | 34.6 | -79.4 | 204.2 | 58.2 | 25.9 | |
| Closing Cash Balance | 214.1 | 289.5 | 336.8 | 260.3 | 225.7 | 305.1 | 100.9 | 42.7 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -7.8 | -8.4 | -13.5 | -17.5 | 137.0 | -17.3 | -11.5 | -31.6 | -30.6 | 137.4 | |
| Closing Cash Balance | 289.5 | 297.3 | 305.8 | 319.2 | 336.8 | 199.8 | 217.1 | 228.6 | 257.2 | 290.9 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -109.2 | -58.3 | -103.6 | -133.2 | -83.0 | -57.9 | -48.6 | -51.4 | |
| Real Free Cash Flow | -133.8 | -105.9 | -135.5 | -152.3 | -93.4 | -61.7 | -50.7 | -53.4 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -12.2 | -9.5 | -17.8 | -18.8 | -33.6 | -19.0 | -16.8 | -34.2 | -33.5 | -24.7 | |
| Real Free Cash Flow | -23.0 | -24.0 | -30.0 | -28.9 | -42.7 | -27.6 | -24.8 | -40.5 | -38.5 | -30.0 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -15 | -24.4 | 179.3 |
| P/S | 4.7 | 20.7 | 390.6 |
| P/B | 3.8 | 8.2 | 113.4 |
| P/FCF | -13.6 | -19.9 | 149.9 |
| Market cap | $1.7 | $2.8 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 15.4 % | 19.7 % | 0 % |
| Debt to Income | -82.6 % | -81.8 % | 0 % |
| Debt to Free cash flow | -74.5 % | -126.5 % | 0 % |
| Interest expense percentage | -8.6 % | -7 % | 11.2 % |
| Current ratio | 8.4 | 9.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -25.1 % | -26.6 % | 0 % |
| ROA | -18.7 % | -22.1 % | 0 % |
| CapEx to Revenue | 2.9 % | 5.4 % | 6 % |
| RaD to Revenue | 0 % | 55.7 % | 0 % |
| ROEM | 407,478.8 | 440849.5 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 64.5 % | 45.9 % | 61.9 % |
| Operating margin | -30.9 % | -149.6 % | 17.9 % |
| Net margin | -28.2 % | -163.4 % | 13 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 55.7 mil | 44.5 mil |
| Employee count | 0.8 tis | 0.5 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
